United States · FDA National Drug Code directory
Sumatriptan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70594-068_44ed271d-bc7e-48f7-bb63-0ecdb70fdad4
- Product NDC
- 70594-068
- Form
- INJECTION
- Composition / generic term
- SUMATRIPTAN SUCCINATE
- Labeler
- Xellia Pharmaceuticals USA LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220101
- Source listing expiry
- 20261231
Source-listed ingredients
- SUMATRIPTAN SUCCINATE — 6 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 VIAL in 1 CARTON (70594-068-02) / .5 mL in 1 VIAL (70594-068-01) · 70594-068-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →